This randomized noninferiority trial assesses the effect of a strategy of active monitoring vs guideline-concordant care on 2-year risk of ipsilateral invasive breast cancer among women with low-risk breast ductal carcinoma in situ.
Artificial intelligence (AI) is enabling us to delve deeply into the information inherent in a mammogram and identify novel features associated with high risk of…
Nicotine limits, bird flu vaccine, latest on UnitedHealthcare exec murder, Tricare, legal issues facing insurers, ADHD diagnoses, and more.
Nature Methods – Approaches for profiling the spatial proteome in tissues are the basis of atlas-scale projects that are delivering on their promise for understanding…
Hyro AI has brought in $35 million in an extension of its series B round, recently securing an investment from Healthier Capital, led by former…
The chronic care management and remote patient monitoring company will be led by veteran healthcare executive Asif Ahmad.
Studies suggest that semaglutide reduces heart attack and stroke and may curb addiction and more. Scientists reflect on the future of GLP-1 drugs beyond weight…
The Endpoints 100 is our semi-regular survey of biotech and pharma executives.
As a seasoned B2B tech influencer and industry expert, I know the power of storytelling in shaping perceptions, driving engagement, and building meaningful connections. This…
Redesign’s new fund announcement follows a series of layoffs and strategic shifts for the company.
Monitor Liver Tests Often for Early Identification of Worsening Liver Function
